Extracellular Vesicles and Their Significance in COVID-19

Sanjay Kumar (Department of Life Science, School of Basic Science and Research, Sharda University, Greater Noida-201310, UP Divison of Nephrology, Mayo Clinic, Rochester, MN, US-55905)
Soumi Sadhu (Department of Life Science, School of Basic Science and Research, Sharda University, Greater Noida-201310, UP)
Himanshu Narayan Singh (Department of System Biology, Columbia University Irving Medical Center, New York, NY 10032)
Navneet Kumar Dubey (Victory Biotechnology Co., Ltd., Taipei 114757, Taiwan; ShiNeo Technology Co., Ltd., New Taipei City 24262, Taiwan)
Nikhil Kumar (Department of Medicine, All India Institute of Medical Sciences (AIIMS), New Delhi-110029)
Prashant Kumar Tiwari (Department of Life Science, School of Basic Science and Research, Sharda University, Greater Noida, UP, 201310, India)
Rajan Malhotra (Department of Life Science, School of Basic Science and Research, Sharda University, Greater Noida, UP, 201310, India)
Himani Sharma (Department of Life Science, School of Basic Science and Research, Sharda University, Greater Noida, UP, 201310, India)

Article ID: 4661

Full Text:



[1] Karn, V., Ahmed, S., Tsai, L.W., et al., 2021. Extracellular Vesicle-Based Therapy for COVID-19:

[2] Promises, Challenges and Future Prospects. Biomedicines. 9, 1373.

[3] DOI: https://doi.org/10.3390/biomedicines9101373

[4] Zhang, J., Kumar, S., Jayachandran, M., et al., 2021. Excretion of Urine Extracellular Vesicles Bearing Markers of Activated Immune Cells and Calcium/ Phosphorus Physiology Differ between Calcium Kidney Stone Formers and Non-Stone Formers. BMC Nephrol. 22, 204.

[5] DOI: https://doi.org/10.1186/s12882-021-02417-8

[6] Jayachandran, M., Yuzhakov, S.V., Kumar, S., et al., 2020. Specific Populations of Urinary Extracellular Vesicles and Proteins Differentiate Type 1 Primary Hyperoxaluria Patients without and with Nephrocalcinosis or Kidney Stones. Orphanet Journal of Rare

[7] Diseases. 15, 1-14. DOI: https://doi.org/10.1186/s13023-020-01607-1

[8] Xu, R., Rai, A., Chen, M., et al., 2018. Extracellular Vesicles in Cancer - Implications for Future Improvements in Cancer Care. Nature Reviews Clinical Oncology. 15, 617-638.

[9] DOI: https://doi.org/10.1038/s41571-018-0036-9

[10] Shetty, A.K., Upadhya, R., 2021. Extracellular Vesicles in Health and Disease. Aging and disease. 12, 1358-1362. DOI: https://doi.org/10.14336/AD.2021.0827

[11] Nagoor Meeran, M.F., Javed, H., Sharma, C., et al., 2021. Can Echinacea Be a Potential Candidate to Target Immunity, Inflammation, and Infection - The Trinity of Coronavirus Disease 2019. Heliyon. 7, e05990. DOI: https://doi.org/10.1016/j.heliyon.2021.e05990

[12] Nagoor Meeran, M.F., Sharma, C., Goyal, S.N., et al., 2020. CB2 Receptor-selective Agonists as Candidates for Targeting Infection, Inflammation, and Immunity in SARS-CoV-2 Infections. Drug Develoment Research. DOI: https://doi.org/10.1002/ddr.21752

[13] Xia, X., Yuan, P., Liu, Y., et al., 2021. Emerging Roles of Extracellular Vesicles in COVID-19, a Double-Edged Sword? Immunology. 163, 416-430. DOI: https://doi.org/10.1111/imm.13329

[14] Pocsfalvi, G., Mammadova, R., Ramos Juarez, A.P., et al., 2020. COVID-19 and Extracellular Vesicles: An Intriguing Interplay. Kidney and Blood Pressure Research. 45, 661-670.

[15] DOI: https://doi.org/10.1159/000511402

[16] Xia, X., Wang, Y., Huang, Y., et al., 2019. Exosomal MiRNAs in Central Nervous System Diseases: Biomarkers, Pathological Mediators, Protective Factors and Therapeutic Agents. Progress in Neurobiology. 183, 101694. DOI: https://doi.org/10.1016/j.pneurobio.2019.101694

[17] Ti, D., Hao, H., Tong, C., et al., 2015. LPS-Preconditioned Mesenchymal Stromal Cells Modify

[18] Macrophage Polarization for Resolution of Chronic Inflammation via Exosome-Shuttled Let-7b. Journal of Translational Medicine. 13, 1-14. DOI: https://doi.org/10.1186/s12967-015-0642-6

[19] Li, J.W., Wei, L., Han, Z., et al., 2019. Mesenchymal Stromal Cells-Derived Exosomes Alleviate Ischemia/ Reperfusion Injury in Mouse Lung by Transporting Anti-Apoptotic MiR-21-5p. European Journal of Pharmacology. 852, 68-76. DOI: https://doi.org/10.1016/j.ejphar.2019.01.022

[20] Hao, Q., Gudapati, V., Monsel, A., et al., 2019. Mesenchymal Stem Cell-Derived Extracellular Vesicles 4 Decrease Lung Injury in Mice. The Journal of Immunology. 203, 1961-1972.

[21] DOI: https://doi.org/10.4049/jimmunol.1801534

[22] Kaur, S.P., Gupta, V., 2020. COVID-19 Vaccine: A Comprehensive Status Report. Virus Research. 288, 198114. DOI: https://doi.org/10.1016/j.virusres.2020.198114

[23] Jeyanathan, M., Afkhami, S., Smaill, F., et al., 2020. Immunological Considerations for COVID-19 Vaccine Strategies. Nature Reviews Immunology. 20, 615-632.

[24] DOI: https://doi.org/10.1038/s41577-020-00434-6

[25] Jb, L.P., 2005. Dexosomes as a Therapeutic Cancer Vaccine: From Bench to Bedside. Blood Cells, Molecules & Diseases. 35. DOI: https://doi.org/10.1016/j.bcmd.2005.06.003

[26] Tan, A., De La Peña, H., Seifalian, A.M., 2010. The Application of Exosomes as a Nanoscale Cancer Vaccine. International Journal of Nanomedicine. 5, 889-900.

[27] DOI: https://doi.org/10.2147/IJN.S13402

[28] Kuate, S., Cinatl, J., Doerr, H.W., et al., 2007. Exosomal Vaccines Containing the S Protein of the SARS Coronavirus Induce High Levels of Neutralizing Antibodies. Virology. 362, 26.

[29] DOI: https://doi.org/10.1016/j.virol.2006.12.011

[30] Théry, C., Ostrowski, M., Segura, E., 2009. Membrane Vesicles as Conveyors of Immune Responses. Nature Reviews Immunology. 9, 581-593. DOI: https://doi.org/10.1038/nri2567

[31] Millar, J.E., Bahr, V.von., Malfertheiner, M.V., et al., 2019. Administration of Mesenchymal Stem Cells during ECMO Results in a Rapid Decline in Oxygenator Performance. Thorax. 74, 194-196,

[32] DOI: https://doi.org/10.1136/thoraxjnl-2017-211439

DOI: https://doi.org/10.30564/ahpr.v4i1.4661


  • There are currently no refbacks.
Copyright © 2022 Advances in Human Physiology Research

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.